vimarsana.com
Home
Live Updates
Genetics in Medicine Publishes Myriad Genetics Patient-Outcomes Study Validating RiskScore® as a Clinical Breast Cancer Risk Assessment Tool : comparemela.com
Genetics in Medicine Publishes Myriad Genetics Patient-Outcomes Study Validating RiskScore® as a Clinical Breast Cancer Risk Assessment Tool
SALT LAKE CITY, June 03, 2024 -- Myriad Genetics, Inc., , a leader in genetic testing and precision medicine, today announced that Genetics in Medicine, an official journal of the American College...
Related Keywords
San Antonio ,
Texas ,
United States ,
Dale Muzzey ,
Allison Kurian ,
Glenn Farrell ,
Matt Scalo ,
Exchange Commission ,
Stanford University School Of Medicine ,
American College Of Medical Genetics ,
Genetics Inc ,
Nasdaq ,
American College ,
Medical Genetics ,
Hereditary Cancer ,
Spotlight Presentation ,
Antonio Breast Cancer Symposium ,
Myrisk Hereditary Cancer Test ,
Stanford University School ,
Private Securities Litigation Reform Act ,
Annual Report ,
Quarterly Reports ,
Current Reports ,
comparemela.com © 2020. All Rights Reserved.